Centre Prohibits 16 Fixed-Dose Combination Medicines to Protect Public Health

In a significant move aimed at strengthening patient safety and ensuring the rational use of medicines, the Central Government has banned the manufacture, sale, distribution, and supply of 16 Fixed-Dose Combination (FDC) drugs across India with immediate effect.

According to the Union Health Ministry, these medicines were found to lack adequate therapeutic justification, and their potential risks were considered greater than their expected benefits. The decision has been taken to ensure that only scientifically validated and effective medicines remain available for public use.

Why Has the Government Banned These Medicines?

The decision follows a comprehensive review of Fixed-Dose Combination drugs conducted under the directions of the Supreme Court. As part of this process, the Drugs Technical Advisory Board (DTAB) appointed an expert committee to evaluate various drug combinations available in the market.

The committee examined whether these combinations were medically justified, effective, and safe for patients. Based on its findings, 16 combinations were identified as irrational or potentially harmful, leading to their prohibition.

What Are Fixed-Dose Combination (FDC) Drugs?

Fixed-Dose Combination drugs contain two or more active pharmaceutical ingredients combined in a predetermined ratio within a single formulation.

While many FDC medicines offer convenience and improve treatment outcomes, some combinations may not provide additional therapeutic benefits and could increase the risk of adverse effects if not scientifically supported.

Immediate Nationwide Ban on 16 Drug Combinations

The Health Ministry has issued notifications under Section 26A of the Drugs and Cosmetics Act, 1940, prohibiting the manufacture, sale, distribution, and supply of the identified FDC drugs for human use throughout the country.

Authorities stated that these combinations were not considered beneficial when compared to the potential health risks associated with their continued use.

Which Types of Medicines Are Included?

The banned formulations belong to multiple therapeutic categories, including:

1. Pain Relief and Antispasmodic Medicines

Certain combinations used for pain management and muscle relaxation have been prohibited after experts found insufficient medical justification for their continued use.

Examples include:

• Acetyl Salicylic Acid + Ethoheptazine

• Dicyclomine + Paracetamol + Clidinium Bromide

• Dicyclomine + Paracetamol + Clidinium Bromide + Chlordiazepoxide

• Paracetamol + Lignocaine

2. Diabetes-Related Combination

A combination containing:

• Gliclazide + Chromium Picolinate

has also been included in the banned list.

3. Antibiotic-Based Combinations

Several antibiotic formulations have been prohibited, including combinations involving:

• Amoxicillin + Serratiopeptidase

• Amoxicillin + Serratiopeptidase + Lactobacillus Sporogenes

• Amoxicillin + Cloxacillin + Lactic Acid Bacillus + Serratiopeptidase

• Cefadroxyl + Probenecid

• Cefuroxime + Serratiopeptidase

4. Dermatology and Skincare Products

Multiple skincare formulations containing Aloe Vera or Aloe Extract combined with ingredients such as:

• Vitamin E

• Jojoba Oil

• Orange Oil

• Wheat Germ Oil

• Tea Tree Oil

• Allantoin

• D-Panthenol

have also been prohibited.

Focus on Patient Safety and Rational Drug Use

The Health Ministry emphasized that the action is part of the government's broader efforts to improve patient safety and promote evidence-based prescribing practices.

Officials noted that several irrational drug combinations have been removed from the market in previous years after scientific evaluations identified concerns regarding their effectiveness and safety.

Strict Compliance Ordered

To ensure smooth implementation, all State Drug Controllers, regulatory authorities, and enforcement agencies have been instructed to strictly enforce the ban.

Manufacturers, importers, distributors, and other stakeholders have also been directed to take immediate corrective measures and comply with the new regulations.

Conclusion

The government's decision to ban 16 Fixed-Dose Combination medicines reflects its ongoing commitment to public health and patient safety. By removing drug combinations that lack sufficient therapeutic value or may pose health risks, authorities aim to encourage the use of scientifically proven treatments and improve the overall quality of healthcare in the country.